← Martin B. Leon

Papers by Martin B. Leon

Page 3 · newest first

101. Left Atrial Appendage Closure or Anticoagulation for Atrial FibrillationNew England Journal of Medicine · 2026
102. Comments and Corrections Corrections to “A Systematic Review on the Development of Transhumeral Prostheses: Structural Design, Control Systems, and Functional Integration”IEEE Access · 2026
103. Five-year outcomes of the early-generation Intrepid transapical transcatheter mitral valve replacement systemEuroIntervention · 2026
104. Transcatheter Treatment of Bicuspid Aortic Valve Stenosis: From Observational Studies to Randomized Clinical TrialsSHILAP Revista de lepidopterología · 2025
105. Foldax LifePolymer and A Novel Polymeric Heart Valve: Pathway to Clinical Evaluation.2025
106. FFRangio-guided versus pressure wire-guided PCI: design and rationale of the multicentre, randomised ALL-RISE trialEuroIntervention · 2025
107. Tricuspid valve replacement outcomes by baseline tricuspid regurgitation severity: the TRISCEND II trialEuropean Heart Journal · 2025
108. The low-risk TAVR trials—A critical appraisal of the current landscapeAmerican Heart Journal · 2025
109. Detecting structural heart disease from electrocardiograms using AINature · 2025
110. Outcomes After Transcatheter Aortic Valve Replacement Among Medicare Beneficiaries: The Impact of Frailty and Social VulnerabilityStructural Heart · 2025
111. Clinical Outcomes for Closure of Iatrogenic Atrial Septal Defects Following Transseptal SAPIEN Mitral Valve-in-Valve ProceduresJournal of the Society for Cardiovascular Angiography & Interventions · 2025
112. Health Care Cost and Resource Utilization After Aortic Valve Replacement According to the Extent of Cardiac DamageCirculation Cardiovascular Interventions · 2025
113. Outcomes of Transcatheter Aortic Valve Replacement in Low-Risk Patients in the United States: A Report From the STS/ACC TVT RegistryCirculation · 2025
114. Cardiac Biomarkers in Patients With Asymptomatic Severe Aortic Stenosis: Analysis From the EARLY TAVR TrialCirculation · 2025
115. Deep learning for echocardiographic assessment and risk stratification of aortic, mitral, and tricuspid regurgitation: the DELINEATE-regurgitation studyEuropean Heart Journal · 2025
116. Low Contrast Strategies in TAVR: Feasibility and Outcomes to Prevent Renal Injury in Chronic Kidney DiseaseCatheterization and Cardiovascular Interventions · 2025
117. Deformation of Surgically Implanted Aortic Valves: CT Findings Prior to Valve-in-Valve Implantation and Association With Mechanism of FailureJournal of the Society for Cardiovascular Angiography & Interventions · 2025
118. Late Clinical Outcomes of Balloon-Expandable Valves in Small AnnuliJACC: Cardiovascular Interventions · 2025
119. Racial Disparities Among Patients Undergoing Balloon-Expandable Transcatheter Aortic Valve ReplacementJournal of the Society for Cardiovascular Angiography & Interventions · 2025
120. Management of Acute Decompensated Valvular Heart DiseaseEuropean Journal of Heart Failure · 2024
121. Aortic Valve Replacement vs Clinical Surveillance in Asymptomatic Severe Aortic StenosisJournal of the American College of Cardiology · 2024
122. Clinical Outcomes According to Aortic Stenosis Management: Insights From Real‐World PracticeJournal of the American Heart Association · 2024
123. Transcatheter Valve Replacement in Severe Tricuspid RegurgitationNew England Journal of Medicine · 2024
124. Outcomes of Balloon-Expandable Transcatheter Aortic Valve Replacement in Younger Patients in the Low-Risk EraJAMA Cardiology · 2024
125. Cerebral Embolic Protection by Geographic RegionJAMA Cardiology · 2024
126. Transcatheter Aortic-Valve Replacement for Asymptomatic Severe Aortic StenosisNew England Journal of Medicine · 2024
127. Acute Valve Syndrome in Aortic StenosisStructural Heart · 2024
128. Long term safety and outcomes after atrial shunting for heart failure with preserved or mildly reduced ejection fraction: 5-year and 3-year follow-up in the REDUCE LAP-HF I and II trialsAmerican Heart Journal · 2024
129. Mitral regurgitation evolution after transcatheter tricuspid valve interventions—a sub-analysis of the TriValve registryEuropean Heart Journal - Cardiovascular Imaging · 2024
130. One-Year Outcomes of Transseptal Mitral Valve-in-Valve in Intermediate Surgical Risk PatientsCirculation Cardiovascular Interventions · 2024
131. Predicting Treatment of Bioprosthetic Aortic Valve Failure in the United States: A Proposed ModelSHILAP Revista de lepidopterología · 2024
132. Outcomes of ultra‐low contrast percutaneous coronary intervention in patients with advanced chronic kidney diseaseCatheterization and Cardiovascular Interventions · 2024
133. Contemporary Review of the Methods for Rapid Ventricular Pacing During Transcatheter Aortic Valve ReplacementStructural Heart · 2024
134. Clinical outcomes with thin versus thick strut polymer-free biolimus-coated stents at 3 yearsOpen Heart · 2024
135. Transcatheter or Surgical Replacement for Failed Bioprosthetic Aortic ValvesJAMA Cardiology · 2024
136. Leaflet modification before transcatheter aortic valve implantation in patients at risk for coronary obstruction: the ShortCut studyEuropean Heart Journal · 2024
137. Cardiac Damage Staging Predicts Outcomes in Aortic Valve Stenosis After Aortic Valve ReplacementJACC Advances · 2024
138. Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus documentEuroIntervention · 2024
139. OR5-2 | Radiation Exposure and Patient Outcomes in IVUS-Guided Near-Zero Contrast PCI versus IVUS-Guided Ultra-Low Contrast PCIJournal of the Society for Cardiovascular Angiography & Interventions · 2024
140. D-46 | IVUS-Guided Ultralow-Contrast PCI in Patients with CKD and Reduced Ejection Fraction: Safety Outcomes AnalysisJournal of the Society for Cardiovascular Angiography & Interventions · 2024
141. Left and right ventricular longitudinal systolic function following aortic valve replacement in the PARTNER 2 trial and registryEuropean Heart Journal - Cardiovascular Imaging · 2024
142. Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection FractionJAMA Cardiology · 2024
143. Off-Label Use of Peripheral Paclitaxel Drug-Coated Balloons in Management of Recurrent Coronary In-Stent RestenosisJournal of the Society for Cardiovascular Angiography & Interventions · 2024
144. Effect of Sex and Flow Status on Outcomes After Surgical or Transcatheter Aortic Valve ReplacementJACC Advances · 2024
145. Resumen: Consenso internacional para la nomenclatura y clasificación de la válvula aórtica bicúspide congénita y su aortopatía, con fines clínicos, quirúrgicos, intervencionistas y de investigaciónArchivos de cardiología de México · 2024
146. First Experience With Augmented Reality Guidance for Cerebral Embolic Protection During TAVRJACC Advances · 2024
147. Ostial right coronary artery lesion morphology and outcomes after treatment with drug-eluting stentsEuroIntervention · 2024
148. Intravascular Imaging–Guided Versus Angiography‐Guided Percutaneous Coronary Intervention: A Systematic Review and Meta‐Analysis of Randomized TrialsJournal of the American Heart Association · 2024
149. Obesity in Heart Failure with Preserved Ejection Fraction: Insights from the REDUCE LAP-HF II TrialEuropean Journal of Heart Failure · 2023
150. Challenges and Future Directions in Redo Aortic Valve Reintervention After Transcatheter Aortic Valve Replacement FailureCirculation Cardiovascular Interventions · 2023